Electronic-components maker Spectrum Control(SPEC Quote - Cramer on SPEC - Stock Picks) has been rated buy since August 2005. The company has reported robust revenue growth, coming in higher than the industry average of 11.5%. Spectrum Control has a solid financial position with reasonable debt levels, solid stock price performance, an impressive record of earnings-per-share growth and compelling growth in net income. These strengths outweigh the company's low profit margins.
National Research(NRCI Quote - Cramer on NRCI - Stock Picks), which provides ongoing survey-based performance measurement for the health care industry, has been rated a buy since November. The company has shown impressive growth in revenue, earnings per share, and net income. Revenue has grown over the year-ago quarter and came in higher than the industry average. These strengths outweigh the fact that the company has had somewhat disappointing return on equity.



